Missouri Trust & Investment Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $110K | Hold |
1,325
| – | – | 0.04% | 155 |
|
2025
Q1 | $107K | Sell |
1,325
-100
| -7% | -$8.11K | 0.04% | 154 |
|
2024
Q4 | $128K | Sell |
1,425
-200
| -12% | -$18K | 0.05% | 143 |
|
2024
Q3 | $161K | Sell |
1,625
-50
| -3% | -$4.94K | 0.06% | 137 |
|
2024
Q2 | $155K | Sell |
1,675
-50
| -3% | -$4.64K | 0.06% | 133 |
|
2024
Q1 | $164K | Buy |
1,725
+1,325
| +331% | +$126K | 0.06% | 133 |
|
2023
Q4 | $35.7K | Hold |
400
| – | – | 0.01% | 225 |
|
2023
Q3 | $29.2K | Hold |
400
| – | – | 0.01% | 228 |
|
2023
Q2 | $33.3K | Hold |
400
| – | – | 0.02% | 222 |
|
2023
Q1 | $30.5K | Sell |
400
-100
| -20% | -$7.62K | 0.02% | 198 |
|
2022
Q4 | $42K | Hold |
500
| – | – | 0.03% | 183 |
|
2022
Q3 | $40K | Hold |
500
| – | – | 0.03% | 186 |
|
2022
Q2 | $37K | Hold |
500
| – | – | 0.02% | 194 |
|
2022
Q1 | $45K | Hold |
500
| – | – | 0.03% | 189 |
|
2021
Q4 | $56K | Buy |
+500
| New | +$56K | 0.03% | 185 |
|